Actively Recruiting
Minipuberty in Infants Born With Potential Hypogonadism Hypogonadotrope
Led by Centre Hospitalier Universitaire Vaudois · Updated on 2022-07-22
100
Participants Needed
1
Research Sites
730 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Disorders of sex development (DSD) occur in 1/3000 births and are defined by variation in aspect of external genital organs, e.g. cryptorchidism, hypospadias and micropenis in male infants and clitoral hypertrophy in female infants. Genetic, hormonal and environmental factors are implicated in DSD. Infants with congenital hypogonadism hypogonadotrope (CHH) can present with DSD. Evaluation of hormonal profile during minipuberty could be of great help to better characterize the etiology of DSD and CHH in particular. Our main objective is to study hormonal profile during the minipuberty of infants born with DSD or born from parents with CHH compared to controls.
CONDITIONS
Official Title
Minipuberty in Infants Born With Potential Hypogonadism Hypogonadotrope
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Infants born with symptoms of disorders of sex development (DSD)
- Infants born from parents with congenital hypogonadotropic hypogonadism (CHH)
You will not qualify if you...
- Premature birth before 35 weeks of gestation
- Male infants with high scrotal cryptorchidism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Canton of Vaud, Switzerland, 1011
Actively Recruiting
Research Team
N
Nelly Pitteloud, MD
CONTACT
R
Research assistant
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here